Short answer

When designing sustained-release drug delivery systems for sensitive biomolecules like proteins, consider hot-melt extrusion as a solvent-free manufacturing method, provided process parameters are rigorously optimized to preserve molecular integrity.

Field: Commercial Production
Source: Refubium (Universitätsbibliothek der Freien Universität Berlin) (2011)
Method: Experimental research and formulation development
Evidence: Strong effect

Hot-melt extrusion (HME) can be effectively utilized to formulate biodegradable implants for sustained parenteral delivery of protein drugs, preserving protein stability and biological activity. This commercial production research insight is drawn from a 2011 study published in Refubium (Universitätsbibliothek der Freien Universität Berlin). Using Experimental research and formulation development, researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing sustained-release drug delivery systems for sensitive biomolecules like proteins, consider hot-melt extrusion as a solvent-free manufacturing method, provided process parameters are rigorously optimized to preserve molecular integrity.

Study

Commercial ProductionHigh ImpactStrong effect

Hot-Melt Extrusion Enables Stable Protein Drug Delivery via Biodegradable Implants

Hot-melt extrusion (HME) can be effectively utilized to formulate biodegradable implants for sustained parenteral delivery of protein drugs, preserving protein stability and biological activity.

Refubium (Universitätsbibliothek der Freien Universität Berlin) · 2011

Key Findings

01Lysozyme was recovered from HME-processed implants with full biological activity.
02The HME process conditions, while requiring optimization, did not inherently destroy protein functionality.
03Optimized HME conditions led to complete active protein recovery.
04Implants demonstrated sustained release of the protein over 60-80 days with maintained enzymatic activity in the final released fractions.

Application

Design takeaway

How to apply

Explore hot-melt extrusion for developing long-acting injectable formulations of protein therapeutics, focusing on precise control of extrusion temperature, screw speed, and feed rate to ensure protein stability.

Project actions

01When researching drug delivery systems, look for studies that use solvent-free manufacturing processes.
02Consider how the manufacturing method itself might affect the stability of sensitive active ingredients.

Method & Evidence

AimTo investigate the feasibility of using hot-melt extrusion for creating biodegradable PLGA implants for extended parenteral protein drug delivery, focusing on protein stability, burst release, and release completeness.

MethodExperimental research and formulation development

ProcedurePLGA implants loaded with a model protein (lysozyme) were prepared using a screw extruder and a syringe-die device. Protein stability was assessed using techniques like DSC, FTIR, and HPLC, alongside biological activity assays. The impact of hydration and release conditions on protein recovery and stability was investigated. Release profiles and enzymatic activity of released protein were monitored over time.

ContextPharmaceutical formulation and drug delivery systems

Variables

IV["Hot-melt extrusion process parameters (temperature, screw speed, feed rate)","PLGA formulation composition (e.g., polymer type, protein loading)"]

DV["Protein stability (e.g., structural integrity, biological activity)","Drug release profile (rate and completeness)","Implant matrix properties (e.g., porosity)"]

CV["Type of model protein (lysozyme)","Type of biodegradable polymer (PLGA)","Release medium composition and temperature"]

Strengths & Limitations

Strengths

+Utilized a solvent-free processing technique (HME), which is advantageous for sensitive compounds.
+Employed multiple analytical methods to assess protein stability and biological activity.
+Demonstrated sustained release over a clinically relevant timeframe.

Limitations

The study focused on one model protein and PLGA. Real-world applications might involve different proteins or polymers, requiring further investigation. The long-term stability and degradation products of the implant and protein were not fully detailed.

Reliability & validity

Reliability could be enhanced by repeating the HME process multiple times under identical conditions and ensuring consistent protein recovery and activity. Validity is supported by using multiple analytical techniques (DSC, FTIR, HPLC, biological assays) to confirm protein stability and by demonstrating consistent release profiles across implant batches.

Think critically

How might the specific properties of different proteins (e.g., size, charge, susceptibility to aggregation) influence the optimal HME parameters required for their stable formulation into biodegradable implants?

Design Principles

"Solvent-free processing techniques like hot-melt extrusion can be leveraged for the stable formulation of sensitive active pharmaceutical ingredients in biodegradable delivery systems."

This research addresses a critical challenge in pharmaceutical design: delivering sensitive protein-based drugs effectively over extended periods. By demonstrating the viability of a solvent-free HME process, it opens avenues for more stable, efficient, and potentially cost-effective manufacturing of advanced drug delivery systems.

What This Means for Your Design

This research shows that a special heating and pressing method called hot-melt extrusion can be used to make tiny, dissolvable implants that slowly release protein medicines in the body, without damaging the medicine.

How to use in your project

1.Reference this study when discussing the challenges of formulating protein drugs and how advanced manufacturing techniques like HME can overcome them.
2.Use it to support claims about the benefits of solvent-free processing for sensitive compounds.

Add to My Project

Quick Cite

Paragraph starter

Research by Ghalanbor (2011) highlights the potential of hot-melt extrusion (HME) as a solvent-free manufacturing technique for biodegradable implants designed for sustained parenteral delivery of protein drugs. The study successfully demonstrated that HME could preserve the biological activity of a model protein (lysozyme) within PLGA implants, achieving complete active recovery and sustained release over an extended period (60-80 days). This approach offers a promising avenue for overcoming formulation challenges associated with protein drug stability, paving the way for more effective and stable long-acting injectable therapies.

Source

Refubium (Universitätsbibliothek der Freien Universität Berlin)

Formulation development of biodegradable implants for extended parenteral delivery of protein drugs

journal · 2011

View source

Questions About This Research

What does the research say about hot-melt extrusion enables stable protein drug delivery via biodegradable implants?: When designing sustained-release drug delivery systems for sensitive biomolecules like proteins, consider hot-melt extrusion as a solvent-free manufacturing method, provided process parameters are rigorously optimized to preserve molecular integrity. Evidence: Refubium (Universitätsbibliothek der Freien Universität Berlin) (2011).
Why does "Hot-Melt Extrusion Enables Stable Protein Drug Delivery via Biodegradable Implants" matter for design?: This research addresses a critical challenge in pharmaceutical design: delivering sensitive protein-based drugs effectively over extended periods. By demonstrating the viability of a solvent-free HME process, it opens avenues for more stable, efficient, and potentially cost-effective manufacturing of advanced drug delivery systems.
How can designers apply this research?: When designing sustained-release drug delivery systems for sensitive biomolecules like proteins, consider hot-melt extrusion as a solvent-free manufacturing method, provided process parameters are rigorously optimized to preserve molecular integrity.
What were the main findings?: Lysozyme was recovered from HME-processed implants with full biological activity.. The HME process conditions, while requiring optimization, did not inherently destroy protein functionality.. Optimized HME conditions led to complete active protein recovery.. Implants demonstrated sustained release of the protein over 60-80 days with maintained enzymatic activity in the final released fractions.
What research method was used?: Experimental research and formulation development.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2011 journal from Refubium (Universitätsbibliothek der Freien Universität Berlin).
What should I do differently in my next project?: Explore hot-melt extrusion for developing long-acting injectable formulations of protein therapeutics, focusing on precise control of extrusion temperature, screw speed, and feed rate to ensure protein stability.
What are the limitations?: The study used a model protein (lysozyme); results may vary for other proteins with different stability profiles. The long-term stability of the protein within the implant matrix beyond the study period was not fully explored. The impact of scale-up on protein stability was not assessed.